| Financial Year |
March 31 2023 |
| Monetary Funds |
386,869,329.36 |
| Held-for-trading Financial Assets |
59,027,726.34 |
| Notes Receivable |
-- |
| Accounts Receivable |
122,095,264.38 |
| Advances to Suppliers |
42,208,948.49 |
| Other Receivables |
35,821,760.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
216,145,442.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,982,430.63 |
| Total Current Assets |
1,245,227,814.53 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
118,373,942.13 |
| Investment Properties |
612,047,050.41 |
| Fixed Assetes |
475,858,775.74 |
| Under-construction Projects |
151,749,265.63 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
240,221,447.44 |
| R&D expenses |
-- |
| Goodwill |
176,759,571.08 |
| Long-Term Deferred and Prepaid Expenses |
6,973,988.94 |
| Deferred Income Tax Assets |
11,349,878.05 |
| Other Non-Current Assets |
242,663.45 |
| Sub-Total of Non-Current Assets |
1,795,265,446.96 |
| Total Assets |
3,040,493,261.49 |
| Short-Term Loans |
17,500,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
50,000,000.00 |
| Accounts Payable |
107,523,169.67 |
| Accounts Received In Advance |
1,416,425.45 |
| Employee Compensation Payable |
25,651,863.48 |
| Taxes Payable |
69,193,990.68 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
60,997,756.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
46,098.03 |
| Other Current Liabilities |
113,583,221.22 |
| Sub-Total of Current Liabilities |
517,057,979.86 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
340,743.30 |
| Deferred Income Tax Liabilities |
73,884,788.45 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
77,582,877.78 |
| Total Liabilities |
594,640,857.64 |
| Paid-In Capital(Or Share Stock) |
401,743,872.00 |
| Capital Surplus |
1,787,285,949.57 |
| Surplus Reserve |
63,991,182.32 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
164,669,280.39 |
| Minority Stockholder's Interest |
28,162,119.57 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,417,690,284.28 |
| Owner's Equity（Stockholder's Equity） |
2,445,852,403.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,040,493,261.49 |
